NCT01339377View on ClinicalTrials.gov

Safety and Effectiveness Study of the AO-1000 Device to Treat Contained Herniated Discs

PHASE1CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions
Disk, Herniated
Interventions
DEVICE

AO-1000

Mixture of 2 weight% ozone in 98 weight% oxygen injected into the nucleus pulposus of a contained herniated disc.

Trial Locations (3)

V5Z 1M9

Vancouver General Hospital, Vancouver

N6H 5A5

University of Western Ontario - London Health Sciences Centre, London

M5T 2S8

Toronto Western Hospital, Toronto

All Listed Sponsors
lead

ActiveO Inc.

INDUSTRY

NCT01339377 - Safety and Effectiveness Study of the AO-1000 Device to Treat Contained Herniated Discs | Biotech Hunter | Biotech Hunter